BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 9592986)

  • 1. ALL1 gene alterations in acute leukemia: biological and clinical aspects.
    Cimino G; Rapanotti MC; Sprovieri T; Elia L
    Haematologica; 1998 Apr; 83(4):350-7. PubMed ID: 9592986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Infant acute leukemias show the same biased distribution of ALL1 gene breaks as topoisomerase II related secondary acute leukemias.
    Cimino G; Rapanotti MC; Biondi A; Elia L; Lo Coco F; Price C; Rossi V; Rivolta A; Canaani E; Croce CM; Mandelli F; Greaves M
    Cancer Res; 1997 Jul; 57(14):2879-83. PubMed ID: 9230194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rearrangements involving chromosome band 11Q23 in acute leukaemia.
    Rowley JD
    Semin Cancer Biol; 1993 Dec; 4(6):377-85. PubMed ID: 8142623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Domains with transcriptional regulatory activity within the ALL1 and AF4 proteins involved in acute leukemia.
    Prasad R; Yano T; Sorio C; Nakamura T; Rallapalli R; Gu Y; Leshkowitz D; Croce CM; Canaani E
    Proc Natl Acad Sci U S A; 1995 Dec; 92(26):12160-4. PubMed ID: 8618864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The AML1 gene: a transcription factor involved in the pathogenesis of myeloid and lymphoid leukemias.
    Lo Coco F; Pisegna S; Diverio D
    Haematologica; 1997; 82(3):364-70. PubMed ID: 9234595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. All patients with the T(11;16)(q23;p13.3) that involves MLL and CBP have treatment-related hematologic disorders.
    Rowley JD; Reshmi S; Sobulo O; Musvee T; Anastasi J; Raimondi S; Schneider NR; Barredo JC; Cantu ES; Schlegelberger B; Behm F; Doggett NA; Borrow J; Zeleznik-Le N
    Blood; 1997 Jul; 90(2):535-41. PubMed ID: 9226152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of complex genomic breakpoint junctions in the t(9;11) MLL-AF9 fusion gene in acute leukemia.
    Super HG; Strissel PL; Sobulo OM; Burian D; Reshmi SC; Roe B; Zeleznik-Le NJ; Diaz MO; Rowley JD
    Genes Chromosomes Cancer; 1997 Oct; 20(2):185-95. PubMed ID: 9331569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distribution of 11q23 breakpoints within the MLL breakpoint cluster region in de novo acute leukemia and in treatment-related acute myeloid leukemia: correlation with scaffold attachment regions and topoisomerase II consensus binding sites.
    Broeker PL; Super HG; Thirman MJ; Pomykala H; Yonebayashi Y; Tanabe S; Zeleznik-Le N; Rowley JD
    Blood; 1996 Mar; 87(5):1912-22. PubMed ID: 8634439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The localization of the HRX/ALL1 protein to specific nuclear subdomains is altered by fusion with its eps15 translocation partner.
    Rogaia D; Grignani F; Carbone R; Riganelli D; LoCoco F; Nakamura T; Croce CM; Di Fiore PP; Pelicci PG
    Cancer Res; 1997 Mar; 57(5):799-802. PubMed ID: 9041173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An in vivo topoisomerase II cleavage site and a DNase I hypersensitive site colocalize near exon 9 in the MLL breakpoint cluster region.
    Strissel PL; Strick R; Rowley JD; Zeleznik-Le NJ
    Blood; 1998 Nov; 92(10):3793-803. PubMed ID: 9808573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular analysis of 13 cases of MLL/11q23 secondary acute leukemia and identification of topoisomerase II consensus-binding sequences near the chromosomal breakpoint of a secondary leukemia with the t(4;11).
    Domer PH; Head DR; Renganathan N; Raimondi SC; Yang E; Atlas M
    Leukemia; 1995 Aug; 9(8):1305-12. PubMed ID: 7643617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MSF (MLL septin-like fusion), a fusion partner gene of MLL, in a therapy-related acute myeloid leukemia with a t(11;17)(q23;q25).
    Osaka M; Rowley JD; Zeleznik-Le NJ
    Proc Natl Acad Sci U S A; 1999 May; 96(11):6428-33. PubMed ID: 10339604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 11q23 rearrangements in acute leukemia.
    Rubnitz JE; Behm FG; Downing JR
    Leukemia; 1996 Jan; 10(1):74-82. PubMed ID: 8558942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complete exon structure of the ALL1 gene.
    Rasio D; Schichman SA; Negrini M; Canaani E; Croce CM
    Cancer Res; 1996 Apr; 56(8):1766-9. PubMed ID: 8620491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel chromosomal inversion at 11q23 in infant acute myeloid leukemia fuses MLL to CALM, a gene that encodes a clathrin assembly protein.
    Wechsler DS; Engstrom LD; Alexander BM; Motto DG; Roulston D
    Genes Chromosomes Cancer; 2003 Jan; 36(1):26-36. PubMed ID: 12461747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute leukemias of different lineages have similar MLL gene fusions encoding related chimeric proteins resulting from chromosomal translocation.
    Corral J; Forster A; Thompson S; Lampert F; Kaneko Y; Slater R; Kroes WG; van der Schoot CE; Ludwig WD; Karpas A
    Proc Natl Acad Sci U S A; 1993 Sep; 90(18):8538-42. PubMed ID: 8378328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The partial tandem duplication of ALL1 (MLL) is consistently generated by Alu-mediated homologous recombination in acute myeloid leukemia.
    Strout MP; Marcucci G; Bloomfield CD; Caligiuri MA
    Proc Natl Acad Sci U S A; 1998 Mar; 95(5):2390-5. PubMed ID: 9482895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Malignant hematopoietic cell lines: in vitro models for the study of MLL gene alterations.
    Drexler HG; Quentmeier H; MacLeod RA
    Leukemia; 2004 Feb; 18(2):227-32. PubMed ID: 14671638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of t(9;11) chromosomal breakpoint sequences in childhood acute leukemia: almost identical MLL breakpoints in therapy-related AML after treatment without etoposides.
    Langer T; Metzler M; Reinhardt D; Viehmann S; Borkhardt A; Reichel M; Stanulla M; Schrappe M; Creutzig U; Ritter J; Leis T; Jacobs U; Harbott J; Beck JD; Rascher W; Repp R
    Genes Chromosomes Cancer; 2003 Apr; 36(4):393-401. PubMed ID: 12619163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The HRX proto-oncogene product is widely expressed in human tissues and localizes to nuclear structures.
    Butler LH; Slany R; Cui X; Cleary ML; Mason DY
    Blood; 1997 May; 89(9):3361-70. PubMed ID: 9129043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.